Sökning: onr:"swepub:oai:DiVA.org:uu-189933" >
Longitudinal Stabil...
Longitudinal Stability Evaluation of Biomarkers and Their Correlation in Cerebrospinal Fluid and Plasma from Patients with Alzheimer's Disease
-
Höglund, Kina, 1976 (författare)
-
Bogstedt, Anna (författare)
-
Fabre, Susanne (författare)
-
visa fler...
-
Aziz, Ali (författare)
-
- Annas, Peter (författare)
- Karolinska Institutet
-
- Basun, Hans (författare)
- Uppsala universitet,Geriatrik
-
Minthon, Lennart (författare)
-
- Lannfelt, Lars (författare)
- Uppsala universitet,Geriatrik
-
- Blennow, Kaj, 1958 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
-
- Andreasen, Niels (författare)
- Karolinska Institutet
-
visa färre...
-
(creator_code:org_t)
- 2012
- 2012
- Engelska.
-
Ingår i: Journal of Alzheimer's Disease. - 1387-2877 .- 1875-8908. ; 32:4, s. 939-947
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.3...
-
https://gup.ub.gu.se...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- There is an increasing demand for biomarkers in clinical treatment trials to demonstrate target engagement and to support disease modification claims. To be able to detect treatment related effects, a prerequisite is that the levels of the biomarker are stable over time or that the change over time is known. In the present study, the stability of alpha- and beta-cleaved soluble amyloid-beta protein precursor (sA beta PP alpha and sA beta PP beta), A beta(1-40) together with the phosphorylated form of neurofilament heavy/medium (pNfH/M) in cerebrospinal fluid (CSF) was analyzed in a cohort of 51 patients with Alzheimer's disease. In addition, the stability of A beta(1-40), beta(1-42), and sA beta PP beta in plasma was explored. Plasma and CSF was sampled at baseline and after 6-months follow up, and all patients were on stable treatment with acetylcholinesterase inhibitors. During this 6-month longitudinal follow-up, we saw a small, but consistent and statistically significant increase in CSF levels of sA beta PP beta (103% of baseline levels) and a statistically significant decrease in the CSF levels of pNfH/M (91% of baseline levels). The mean level of the CSF biomarkers were very stable between baseline and endpoint, with within-patients coefficients of variation (CVs) of 5.84-17.3%, while the variability was larger for the plasma biomarkers, with CVs of 14.1-42.3%. This stability suggests that these biomarkers may have the potential to detect and monitor biochemical changes induced by disease-modifying drugs.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Neurosciences (hsv//eng)
Nyckelord
- Alzheimer's disease
- biomarkers
- cerebrospinal fluid
- longitudinal
- plasma
- stability
- Alzheimer's disease
- biomarkers
- cerebrospinal fluid
- longitudinal
- plasma
- stability
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Höglund, Kina, 1 ...
-
Bogstedt, Anna
-
Fabre, Susanne
-
Aziz, Ali
-
Annas, Peter
-
Basun, Hans
-
visa fler...
-
Minthon, Lennart
-
Lannfelt, Lars
-
Blennow, Kaj, 19 ...
-
Andreasen, Niels
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Neurovetenskaper
- Artiklar i publikationen
-
Journal of Alzhe ...
- Av lärosätet
-
Uppsala universitet
-
Göteborgs universitet
-
Karolinska Institutet